Literature DB >> 30691280

Invisible and intangible illness: a qualitative interview study of patients' experiences and understandings of conservatively managed end-stage kidney disease.

Katherine Bristowe1, Lucy E Selman2, Irene J Higginson3, Fliss E M Murtagh4.   

Abstract

BACKGROUND: Increasing numbers of older adults are living with kidney disease. For those with comorbidities, conservative management of end-stage kidney disease is a viable option: dialysis may afford limited or no survival benefit, and perceived burdens may outweigh benefits. Conservative management focuses on: maintaining remaining kidney function; symptom management; and quality of life. Common symptoms in conservatively managed kidney disease include: fatigue; anorexia; nausea and vomiting; pain and pruritis. Chronic disease is associated with biographical disruption and a loss of sense of self. Coping strategies are shaped by illness perceptions, but little is known of illness perceptions of people living with conservatively managed kidney disease. This study aimed to explore the experience, impact and understanding of conservatively managed end-stage kidney disease among older adults.
METHODS: Secondary analysis of qualitative interviews analysed using thematic analysis. Twenty people with conservatively managed end-stage kidney disease were recruited from 3 UK renal units: median age was 82 (range, 69-95); 9 women, 11 men.
RESULTS: Participants described the invisibility and intangibility of kidney disease, and challenges in attributing symptoms to the disease. They described a spectre-like presence, sapping their energy and holding them down. For some, it was hard to differentiate symptoms of the illness from characteristics of aging, resulting in challenges in illness attribution, and disconnectedness from the illness.
CONCLUSIONS: Participants described challenges in attributing their symptoms to kidney disease which negatively impacted upon their wellbeing, and ability to accept an adjusted sense of self. Understanding these challenges is critical in the management conditions such as end-stage kidney disease where prognosis may be poor, and where an increase in symptom distress may suggest a marked deterioration in their condition, or a change in phase of illness. Clinical services need to recognize the illness experience (alongside more symptom led approaches), including the invisibility, intangibility, and disconnectedness, and address this through specific interventions focused on improving clinical assessment, communication and education, alongside peer and professional support.

Entities:  

Keywords:  End-stage kidney disease; conservative care; palliative care; qualitative research

Mesh:

Year:  2019        PMID: 30691280     DOI: 10.21037/apm.2018.12.06

Source DB:  PubMed          Journal:  Ann Palliat Med        ISSN: 2224-5820


  7 in total

Review 1.  The psychosocial needs of patients who have chronic kidney disease without kidney replacement therapy: a thematic synthesis of seven qualitative studies.

Authors:  Christina Seery; Sarah Buchanan
Journal:  J Nephrol       Date:  2022-09-01       Impact factor: 4.393

2.  Pain management in patients with chronic kidney disease and end-stage kidney disease.

Authors:  Payel J Roy; Melanie Weltman; Laura M Dember; Jane Liebschutz; Manisha Jhamb
Journal:  Curr Opin Nephrol Hypertens       Date:  2020-11       Impact factor: 3.416

3.  The views and experiences of older people with conservatively managed renal failure: a qualitative study of communication, information and decision-making.

Authors:  Lucy Ellen Selman; Katherine Bristowe; Irene J Higginson; Fliss E M Murtagh
Journal:  BMC Nephrol       Date:  2019-02-04       Impact factor: 2.388

4.  Do patients with high versus low treatment and illness burden have different needs? A mixed-methods study of patients living on dialysis.

Authors:  Kasey R Boehmer; Kathleen H Pine; Samantha Whitman; Paige Organick; Anjali Thota; Nataly R Espinoza Suarez; Christina M LaVecchia; Alexander Lee; Emma Behnken; Bjorg Thorsteinsdottir; Aditya S Pawar; Annika Beck; Elizabeth C Lorenz; Robert C Albright
Journal:  PLoS One       Date:  2021-12-28       Impact factor: 3.752

5.  Palliative Care in Patients with End-Stage Renal Disease: A Meta Synthesis.

Authors:  Nur Fithriyanti Imamah; Hung-Ru Lin
Journal:  Int J Environ Res Public Health       Date:  2021-10-11       Impact factor: 3.390

6.  Immune globulin therapy and kidney disease: Overview and screening, monitoring, and management recommendations.

Authors:  Roger H Kobayashi; Michael T Rigas
Journal:  Am J Health Syst Pharm       Date:  2022-08-19       Impact factor: 2.980

Review 7.  Kidney disease pathways, options and decisions: an environmental scan of international patient decision aids.

Authors:  Anna E Winterbottom; Andrew Mooney; Lynne Russon; Vicki Hipkiss; Lucy Ziegler; Richard Williams; Jeanette Finderup; Hilary L Bekker
Journal:  Nephrol Dial Transplant       Date:  2020-12-04       Impact factor: 5.992

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.